CN1091521A - 靶成分测定法 - Google Patents

靶成分测定法 Download PDF

Info

Publication number: CN1091521A
Authority: CN; China
Prior art keywords: vesicle; proportion; antibody; mixed liquor; liposome
Prior art date: 1992-02-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CN93101332A

Other languages

English (en)

Chinese (zh)

Inventor

罗伯特·A·莱维

S·C·瓦德劳

R·罗德里古兹

J·布里茨

T·J·莫阔里诺

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Becton Dickinson and Co

Original Assignee

Becton Dickinson and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-25

Filing date

1993-02-24

Publication date

1994-08-31

1993-02-24 Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co

1994-08-31 Publication of CN1091521A publication Critical patent/CN1091521A/zh

Status Pending legal-status Critical Current

Links

238000003556 assay Methods 0.000 title abstract description 3
239000002502 liposome Substances 0.000 claims abstract description 58
239000002245 particle Substances 0.000 claims abstract description 10
239000000203 mixture Substances 0.000 claims description 39
238000000034 method Methods 0.000 claims description 36
239000000427 antigen Substances 0.000 claims description 26
102000036639 antigens Human genes 0.000 claims description 26
108091007433 antigens Proteins 0.000 claims description 26
239000008280 blood Substances 0.000 claims description 24
210000004369 blood Anatomy 0.000 claims description 23
239000000126 substance Substances 0.000 claims description 16
239000000463 material Substances 0.000 claims description 15
239000013060 biological fluid Substances 0.000 claims description 14
210000004027 cell Anatomy 0.000 claims description 13
238000012113 quantitative test Methods 0.000 claims description 13
210000003743 erythrocyte Anatomy 0.000 claims description 12
201000004792 malaria Diseases 0.000 claims description 7
210000001744 T-lymphocyte Anatomy 0.000 claims description 5
239000012530 fluid Substances 0.000 claims description 3
241000224016 Plasmodium Species 0.000 claims description 2
241000223960 Plasmodium falciparum Species 0.000 claims description 2
239000002775 capsule Substances 0.000 claims 2
239000006260 foam Substances 0.000 claims 2
210000002706 plastid Anatomy 0.000 claims 1
239000007850 fluorescent dye Substances 0.000 abstract description 2
230000005484 gravity Effects 0.000 abstract 2
239000000523 sample Substances 0.000 description 24
239000000975 dye Substances 0.000 description 9
239000007788 liquid Substances 0.000 description 7
210000004698 lymphocyte Anatomy 0.000 description 7
238000012360 testing method Methods 0.000 description 7
230000000527 lymphocytic effect Effects 0.000 description 6
230000003211 malignant effect Effects 0.000 description 6
238000005516 engineering process Methods 0.000 description 4
JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 4
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 4
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
238000004159 blood analysis Methods 0.000 description 3
230000008859 change Effects 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
230000006872 improvement Effects 0.000 description 3
239000003550 marker Substances 0.000 description 3
230000003647 oxidation Effects 0.000 description 3
238000007254 oxidation reaction Methods 0.000 description 3
102000002070 Transferrins Human genes 0.000 description 2
108010015865 Transferrins Proteins 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000003513 alkali Substances 0.000 description 2
230000017531 blood circulation Effects 0.000 description 2
230000001447 compensatory effect Effects 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
239000012528 membrane Substances 0.000 description 2
210000004379 membrane Anatomy 0.000 description 2
230000008569 process Effects 0.000 description 2
230000002787 reinforcement Effects 0.000 description 2
229910000033 sodium borohydride Inorganic materials 0.000 description 2
239000012279 sodium borohydride Substances 0.000 description 2
235000013024 sodium fluoride Nutrition 0.000 description 2
239000011775 sodium fluoride Substances 0.000 description 2
JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 1
201000010374 Down Syndrome Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
102000006354 HLA-DR Antigens Human genes 0.000 description 1
108010058597 HLA-DR Antigens Proteins 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
206010061548 Red blood cell abnormality Diseases 0.000 description 1
206010039966 Senile dementia Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
206010044688 Trisomy 21 Diseases 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
230000000078 anti-malarial effect Effects 0.000 description 1
239000003430 antimalarial agent Substances 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
239000002585 base Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
230000007969 cellular immunity Effects 0.000 description 1
229930183167 cerebroside Natural products 0.000 description 1
RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000013016 damping Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000003814 drug Substances 0.000 description 1
229960001484 edetic acid Drugs 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000007667 floating Methods 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000007429 general method Methods 0.000 description 1
229930182470 glycoside Natural products 0.000 description 1
150000002338 glycosides Chemical class 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
230000036541 health Effects 0.000 description 1
230000004727 humoral immunity Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
208000024335 physical disease Diseases 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
241000894007 species Species 0.000 description 1
239000008107 starch Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Manufacturing Of Micro-Capsules (AREA)

CN93101332A 1992-02-25 1993-02-24 靶成分测定法 Pending CN1091521A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US84197692A	1992-02-25	1992-02-25
US07/841,976		1992-02-25

Publications (1)

Publication Number	Publication Date
CN1091521A true CN1091521A (zh)	1994-08-31

Family

ID=25286232

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN93101332A Pending CN1091521A (zh)	1992-02-25	1993-02-24	靶成分测定法

Country Status (17)

Country	Link
US (1)	US5593848A (2)
EP (1)	EP0557595B1 (2)
JP (1)	JP2925105B2 (2)
CN (1)	CN1091521A (2)
AT (1)	ATE155889T1 (2)
AU (1)	AU662571B2 (2)
BR (1)	BR9300639A (2)
CA (1)	CA2090282A1 (2)
DE (1)	DE69221118T2 (2)
DK (1)	DK0557595T3 (2)
ES (1)	ES2106121T3 (2)
FI (1)	FI930821L (2)
GR (1)	GR3024970T3 (2)
MX (1)	MX9300965A (2)
NO (1)	NO930649L (2)
RU (1)	RU2116068C1 (2)
TW (1)	TW246716B (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102788879A (zh) *	2011-05-20	2012-11-21	常州康卫生物技术有限公司	一种生物检测试剂

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5342790A (en) *	1992-10-30	1994-08-30	Becton Dickinson And Company	Apparatus for indirect fluorescent assay of blood samples
AU4101697A (en) *	1996-11-22	1998-05-28	Robert A. Levine	Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
US6197523B1 (en)	1997-11-24	2001-03-06	Robert A. Levine	Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
AU9233698A (en) *	1997-11-22	1999-06-17	Robert A. Levine	Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6911315B2 (en) *	1997-11-24	2005-06-28	David L. Rimm	Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
TR200003732T2 (tr) *	1998-06-26	2001-06-21	Pfizer Products Inc.	Aminlerin Schiff-bazlı yaklaşımlarının hazırlanmasına yönelik gelişmiş işlem
GB0021303D0 (en) *	2000-08-30	2000-10-18	Medinnova Sf	Use
WO2004042019A2 (en) *	2002-10-30	2004-05-21	Pointilliste, Inc.	Systems for capture and analysis of biological particles and methods using the systems
JP2007528854A (ja) *	2003-07-09	2007-10-18	カリフォルニアパシフィックメディカルセンター	細胞への物質送達の遠隔検出
US7996825B2 (en) *	2003-10-31	2011-08-09	Hewlett-Packard Development Company, L.P.	Cross-file inlining by using summaries and global worklist
US20060018911A1 (en) *	2004-01-12	2006-01-26	Dana Ault-Riche	Design of therapeutics and therapeutics
US8221985B2 (en) *	2008-04-02	2012-07-17	Abbott Point Of Care, Inc.	Self-calibrating gradient dilution in a constituent assay and gradient dilution apparatus performed in a thin film sample
WO2009126505A1 (en) *	2008-04-09	2009-10-15	Abbott Point Of Care, Inc.	Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
FR2965273B1 (fr) *	2010-09-29	2015-07-17	Centre Nat Rech Scient	Procede de preparation d'une structure chimique presentant une partition de phases, apte a generer un spectre de fluorescence specifique et ses applications
US9624474B2 (en)	2010-12-01	2017-04-18	Samsung Electronics Co, Ltd.	Method of separating target cell in biological sample
ES2881977T3 (es) *	2015-05-06	2021-11-30	Seracare Life Sciences Inc	Preparaciones liposomales para cribado no invasivo prenatal o de cáncer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3862303A (en) *	1972-02-02	1975-01-21	Atomic Energy Commission	Method for rapid detection and identification of serological factors
US4027660A (en) *	1976-04-02	1977-06-07	Wardlaw Stephen C	Material layer volume determination
US4181609A (en) *	1977-12-20	1980-01-01	Levine Robert A	Blood constituents testing method
DE3000483A1 (de) *	1979-01-09	1980-07-17	Fuji Photo Film Co Ltd	Mikrokapseln fuer immunologische bestimmungen
US4332785A (en)	1980-04-09	1982-06-01	University Patents, Inc.	Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
IL64878A (en) *	1982-01-27	1986-01-31	Yissum Res Dev Co	Method for detection of and determination of malaria antibodies and malaria antigens in human blood
JPS5984162A (ja) *	1982-11-05	1984-05-15	Toshiba Corp	免疫分析法
US4591570A (en) *	1983-02-02	1986-05-27	Centocor, Inc.	Matrix of antibody-coated spots for determination of antigens
JPS6035267A (ja) *	1983-08-05	1985-02-23	Fuji Photo Film Co Ltd	多項目免疫検査法
US5011771A (en) *	1984-04-12	1991-04-30	The General Hospital Corporation	Multiepitopic immunometric assay
FR2571498B1 (fr) *	1984-10-04	1988-04-08	Immunotech Sa	Procede de separation de cellules utilisant des anticorps et des billes de faible densite
JPS6345563A (ja) *	1986-04-11	1988-02-26	Hitachi Ltd	細胞分析方法
US5001225A (en) *	1986-12-08	1991-03-19	Georgetown University	Monoclonal antibodies to a pan-malarial antigen
GB2200448B (en) *	1987-01-23	1991-01-16	Univ London	Targetted liposomes and their use in immunoassay
US5017472A (en) *	1987-09-09	1991-05-21	Bankert Richard B	Microflotation devices used for immunoassays and cell/molecular fractionation
US4978625A (en) *	1987-10-19	1990-12-18	Becton, Dickinson And Company	Fluorescence immunoassay using water insoluble dyes
FR2656233B1 (fr) *	1989-12-22	1993-11-26	Syntex Inc	Procede pour separer des constituants dans un melange.
JPH03249561A (ja) *	1990-02-28	1991-11-07	Toshiba Corp	免疫分析試薬

1992
- 1992-12-01 ES ES92120505T patent/ES2106121T3/es not_active Expired - Lifetime
- 1992-12-01 EP EP92120505A patent/EP0557595B1/en not_active Expired - Lifetime
- 1992-12-01 DE DE69221118T patent/DE69221118T2/de not_active Expired - Fee Related
- 1992-12-01 AT AT92120505T patent/ATE155889T1/de active
- 1992-12-01 DK DK92120505.0T patent/DK0557595T3/da active
- 1992-12-02 AU AU29836/92A patent/AU662571B2/en not_active Ceased
1993
- 1993-02-19 BR BR9300639A patent/BR9300639A/pt not_active Application Discontinuation
- 1993-02-23 MX MX9300965A patent/MX9300965A/es unknown
- 1993-02-24 TW TW082101315A patent/TW246716B/zh active
- 1993-02-24 FI FI930821A patent/FI930821L/fi unknown
- 1993-02-24 CA CA002090282A patent/CA2090282A1/en not_active Abandoned
- 1993-02-24 RU RU93004564A patent/RU2116068C1/ru active
- 1993-02-24 JP JP5035368A patent/JP2925105B2/ja not_active Expired - Lifetime
- 1993-02-24 CN CN93101332A patent/CN1091521A/zh active Pending
- 1993-02-24 NO NO93930649A patent/NO930649L/no unknown
1994
- 1994-11-07 US US08/335,310 patent/US5593848A/en not_active Expired - Fee Related
1997
- 1997-10-09 GR GR970402612T patent/GR3024970T3/el unknown

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102788879A (zh) *	2011-05-20	2012-11-21	常州康卫生物技术有限公司	一种生物检测试剂

Also Published As

Publication number	Publication date
FI930821A7 (fi)	1993-08-26
EP0557595B1 (en)	1997-07-23
MX9300965A (es)	1994-08-31
BR9300639A (pt)	1993-08-31
AU2983692A (en)	1993-08-26
JPH0821833A (ja)	1996-01-23
ATE155889T1 (de)	1997-08-15
FI930821L (fi)	1993-08-26
NO930649D0 (no)	1993-02-24
TW246716B (2)	1995-05-01
DK0557595T3 (da)	1997-12-29
ES2106121T3 (es)	1997-11-01
EP0557595A2 (en)	1993-09-01
RU2116068C1 (ru)	1998-07-27
NO930649L (no)	1993-08-26
DE69221118T2 (de)	1998-02-26
DE69221118D1 (de)	1997-09-04
EP0557595A3 (2)	1993-11-10
JP2925105B2 (ja)	1999-07-28
FI930821A0 (fi)	1993-02-24
US5593848A (en)	1997-01-14
AU662571B2 (en)	1995-09-07
GR3024970T3 (en)	1998-01-30
CA2090282A1 (en)	1993-08-26

Legal Events

Date	Code	Title
1993-12-08	C10	Entry into substantive examination
1993-12-08	SE01	Entry into force of request for substantive examination
1994-08-31	C06	Publication
1994-08-31	PB01	Publication
2000-11-01	C01	Deemed withdrawal of patent application (patent law 1993)
2000-11-01	WD01	Invention patent application deemed withdrawn after publication

Publication	Publication Date	Title
CN1091521A (zh)	1994-08-31	靶成分测定法
TW297094B (2)	1997-02-01
US6114179A (en)	2000-09-05	Method and test kit for detecting antigens and/or antibodies
US3915805A (en)	1975-10-28	Quantitative detection of endotoxin in biological fluids
KR940002520B1 (ko)	1994-03-25	고체-상 분석장치 및 분석방법
US4639419A (en)	1987-01-27	Immunological color change test involving two differently colored reagent spots
JPH01163662A (ja)	1989-06-27	抗原および／又は抗体の検出方法および検出用の試験キット
EP1059534A2 (en)	2000-12-13	Simultaneous determination of forward and reverse ABO blood group
WO1998021593A1 (en)	1998-05-22	SIMULTANEOUS HUMAN ABO AND Rh(D) BLOOD TYPING OR ANTIBODY SCREENING BY FLOW CYTOMETRY
US4695553A (en)	1987-09-22	Method for increasing agglutination of groups of cells to produce improved cell layer interface in centrifuged blood sample using antibodies
US20120244630A1 (en)	2012-09-27	Multiplexed analyte concentration measurement
El Hoss et al.	2018	A novel non-invasive method to measure splenic filtration function in humans
JPH02296150A (ja)	1990-12-06	血液試験法
EP0082862B1 (en)	1986-01-29	A method of detecting or determining histamine in histamine containing materials, particularly body fluids and an analytical means for use in such method
WO2002075313A1 (en)	2002-09-26	A kit and method for detecting fecal parasites
EP0241042A2 (en)	1987-10-14	A method for cell analysis
CN1312477C (zh)	2007-04-25	不同阻抗系列免疫微球及制备方法、以及对其进行检测的方法与装置
Trudell	2005	Detection and identification of antibodies
Price et al.	1964	Disc electrophoresis on polyacrylamide gels of serum mucoids of individuals with selected chronic diseases
JPS6281567A (ja)	1987-04-15	粒子凝集反応を用いる定量方法
CN107328941A (zh)	2017-11-07	一种可同时检测多种细胞粘附因子的抗体芯片
CN1209615C (zh)	2005-07-06	测定生物活性物质的目视荧光免疫分析法
JP3618797B2 (ja)	2005-02-09	免疫測定法
Hevessy et al.	2005	Mean fluorescence intensity rate is a useful marker in the detection of paroxysmal nocturnal hemoglobinuria clones.
WO1987006345A1 (en)	1987-10-22	Colorimetric ratioing immunoassay

CN1091521A - 靶成分测定法 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=25286232

Family Applications (1)

Country Status (17)

Cited By (1)

Families Citing this family (16)

Family Cites Families (18)

Cited By (1)

Also Published As

Similar Documents

Legal Events